Literature DB >> 11442280

Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration.

E Nicolaides1, M Symillides, J B Dressman, C Reppas.   

Abstract

PURPOSE: To quantitatively compare in vitro dissolution data in biorelevant and compendial media, to investigate whether in vitro differences are reflected in the simulated plasma profile and to specify under which circumstances prediction of the plasma profile of orally administered lipophilic drugs can be achieved.
METHODS: Previously published dissolution data from seven products of four lipophilic drugs were compared using the first order model, the RRSBW distribution, and a model based on the Noyes-Whitney theory. Simulated plasma profiles were then obtained using a model-dependent approach. Simulated and observed plasma profiles were compared with the difference factor, f1.
RESULTS: No model consistently provided the best fit to the in vitro data, which varied significantly with medium composition. Prediction of the plasma profile was possible (9.6 < or = f1 < or = 34.2) in seven out of eleven cases.
CONCLUSIONS: Although prediction of the plasma profile of lipophilic drugs solely on the basis of in vitro data remains an ambitious target, this study shows that the plasma profile of a lipophilic drug can be predicted with appropriate in vitro dissolution data, provided that the absolute bioavailability of the drug is known and the drug has dissolution limited absorption.

Mesh:

Substances:

Year:  2001        PMID: 11442280     DOI: 10.1023/a:1011071401306

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.

Authors:  A Kalampokis; P Argyrakis; P Macheras
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

2.  Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide.

Authors:  R Löbenberg; J Krämer; V P Shah; G L Amidon; J B Dressman
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 3.  Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

Authors:  L X Yu; E Lipka; J R Crison; G L Amidon
Journal:  Adv Drug Deliv Rev       Date:  1996-06-12       Impact factor: 15.470

4.  Effect of change in shape factor of a single crystal on its dissolution behavior.

Authors:  M V Dali; J T Carstensen
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

5.  In-vitro dissolution profile comparison: statistics and analysis, model dependent approach.

Authors:  P M Sathe; Y Tsong; V P Shah
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

6.  Development of predictive pharmacokinetic simulation models for drug discovery.

Authors:  D A Norris; G D Leesman; P J Sinko; G M Grass
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

7.  Gastric juice as a dissolution medium: surface tension and pH.

Authors:  M Efentakis; J B Dressman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

8.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

9.  Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data.

Authors:  L X Yu; G L Amidon
Journal:  Eur J Pharm Biopharm       Date:  1998-03       Impact factor: 5.571

10.  Examination of some factors responsible for a food-induced increase in absorption of atovaquone.

Authors:  P E Rolan; A J Mercer; B C Weatherley; T Holdich; H Meire; R W Peck; G Ridout; J Posner
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

View more
  21 in total

1.  A novel strategy for physiologically based predictions of human pharmacokinetics.

Authors:  Hannah M Jones; Neil Parrott; Karin Jorga; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

Authors:  Hannah M Jones; Neil Parrott; Gerd Ohlenbusch; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.

Authors:  Ekarat Jantratid; Niels Janssen; Christos Reppas; Jennifer B Dressman
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

4.  Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note.

Authors:  Namita B Prabhu; Ajit S Marathe; SatishKumar Jain; Pirthi Pal Singh; Kiran Sawant; Leena Rao; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

5.  Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.

Authors:  Ryusuke Takano; Kentaro Furumoto; Koji Shiraki; Noriyuki Takata; Yoshiki Hayashi; Yoshinori Aso; Shinji Yamashita
Journal:  Pharm Res       Date:  2008-06-17       Impact factor: 4.200

6.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

7.  In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match?

Authors:  John Z Duan; Kareen Riviere; Patrick Marroum
Journal:  Pharm Res       Date:  2011-02-02       Impact factor: 4.200

8.  Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media.

Authors:  Anita Maria Persson; Curt Pettersson; Josefin Rosén
Journal:  Pharm Res       Date:  2010-03-27       Impact factor: 4.200

9.  Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.

Authors:  Tycho Heimbach; Binfeng Xia; Tsu-han Lin; Handan He
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

Review 10.  Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects.

Authors:  N Parrott; V Lukacova; G Fraczkiewicz; M B Bolger
Journal:  AAPS J       Date:  2009-01-29       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.